US Supreme Court Rejects Pfizer Prempro Appeal

Printer-friendly version
By: 
BHI

In a blow to the drugmaker, the US Supreme Court rejected a bid by Pfizer to appeal a $58 million damages award made four years ago to three Nevada women, who claimed they suffered breast cancer after taking the Prempro hormone replacement therapy made by its Wyeth unit. The decision comes after the Nevada Supreme Court last November upheld the earlier decision.

Click HERE to read more on this story as reported in the news.

Resources

BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.
Read more...

Webinars

BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.
Read more...

Forums

Join the conversation with BHI Online's forums aimed at providing information through communities.
Read more...

Latest News

A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.
Read more...

Get In Touch

Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.
Read more...

Sub Page: Side Block 1

Sub Page: Side Block 2

Sub Page: Side Block 3

Sub Page: Side Block 4